← All trials
NCT03068741
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2017
- Primary completion
- Dec 1, 2021
- Completion date
- Dec 1, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 2040
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Sunnybrook Health Sciences CentreLead sponsor
- University of TorontoOverall official - principal investigator
- University of TorontoSponsor investigator
- University of TorontoCollaborator
- Canadian Institutes of Health Research (CIHR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.